Member Info for CrustyPete

Plus:

https://www.bluestarhelium.com/wp-content/uploads/2025/11/61296199.pdf

Nothing "new" but good PR nonetheless.

https://www.linkedin.com/company/helium-one/posts/?feedView=all

"know" not "now", sorry.

I suspect Botski that they, the MM's, now full well that, no matter how may get bought they have a bottomless supply of them at anything above 10.0p. Eventually, I hope, that supply ought to run out but that certainly doesn't appear to have happened quite yet......

Even on a day like today after good news and decent buying volumes we still can't keep any upward momentum; every rise gets sold into - bloody disappointing.

Ho hum, the deal that will change our fortunes is surely not far away....

I wish you all a great weekend one and all.

That all makes total sense EE and let's hope you are right on the "deals" front; again Phil has done much to flag the possibility and raise expectations, if he or Scancell doesn't deliver on this over coming weeks and months it may disappoint the market. It is always better to under promise and overdeliver.

All very positive and nothing that wasn't all well flagged in advance and with more to come over the next few weeks but it will be interesting to see if it has a positive and lasting sp impact.

We were delighted to welcome our shareholders at our Annual General Meeting last week, where all resolutions proposed were duly passed.

The event was well attended and we especially enjoyed the engaging Q&A session, which followed CEO Phil L'Huillier's presentation reviewing the Scancell portfolio and upcoming opportunities for value creation.

We would like to thank our shareholders for attending and for their continuing support for Scancell, as we continue to develop novel active immunotherapies for a cancer-free future.

https://lnkd.in/eCWAs7KS

hashtag#AGM hashtag#ShareholderMeeting hashtag#Biotech hashtag#Cancer hashtag#CancerFree hashtag#Oncology hashtag#Governance

Of not great consequence but good to see Scancell keeping up the good work on the PR front.....

https://www.linkedin.com/company/scancell-limited/posts/?feedView=all

Thank you BB, point well made and accepted ;0)

If ABC had been selling down with that intention BB they would have had to announce their sales under DTR 5 rules.... they haven't, not at least to my notice.

How many of these shares will be liquidated into the market over coming weeks and months? Pulsar is a very illiquid market and whilst ABC are a longstanding shareholder and supporter of Pulsar, what %age holding do they feel comfortable with?

Agreed BlueSquare and now without any short term funding issues and with "production" in a matter of weeks so , in my view, we should be seeing a considerable premium over and above that before too long. Though where it settles will depend a lot on the outcome of the ESP results from Itumbula methinks.

Yes indeed TF, the links to Biotechgate certainly and a much fuller version too; I think it was Marcus1234 that provided the links a couple of weeks ago? Apologies if not. But I was simply highlighting the fact that Scancell were keen to broadcast it on LinkedIn whilst highlighting that the company is about to go through a very busy, newsworthy and data heavy period. Lets hope that it the news includes a number of sp catalysts to finally provide some upward momentum to the share price.

More:-

"We’re expecting a busy few months at Scancell.

There are several near-term clinical data catalysts with both iSCIB1+ in the SCOPE study and the Modi-1 Moditope® active immunotherapy. And we will be focusing on design, fundraising and execution of randomised trials of iSCIB1+ towards registration, as well as moving forward our GlyMab® antibodies pipeline and unlocking value there.

Check out Phil L'Huillier's summary of what’s ahead in this clip, taken from his Biotechgate panel discussion with Chris Maggos at Cohesion Bureau and Belichard Pierre at Enterome.

How do results compare to melanoma SoC https://lnkd.in/eHdy3t-m

hashtag#Biotech hashtag#Cancer hashtag#CancerFree hashtag#Oncology hashtag#ImmunoBody hashtag#Immunotherapy hashtag#ClinicalData

How do results compare to melanoma SoC"

Apologies if this has already been posted but a really positive and useful post from Scancell on linkedin.

https://www.linkedin.com/company/scancell-limited/posts/

Not much dry powder for taking advantage (just £2k's worth this morning) but I fully agree with the sentiment - delays maybe (its an occupational hazard in Tanzania) but actually not much news that can possibly harm the sp over coming weeks and months methinks and an AGM too; which I for on am very much looking forward to.

Thank you EE a very fulsome and useful summary.

Have a great weekend one and all I am off for a weekend break ;0)

Maybe McNol but it wouldn't surprise me if any forthcoming Operational Update is withheld to form part of the AGM presentation - that is only a few weeks away now; unless the ESP results themselves are available before then.